(NASDAQ: TLPH) Talphera's forecast annual revenue growth rate of 347.55% is forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 7.54%, and it is also forecast to beat the US market's average forecast revenue growth rate of 11.71%.
Talphera's revenue in 2025 is $281,000.On average, 1 Wall Street analysts forecast TLPH's revenue for 2026 to be $85,146,090, with the lowest TLPH revenue forecast at $85,146,090, and the highest TLPH revenue forecast at $85,146,090. On average, 1 Wall Street analysts forecast TLPH's revenue for 2027 to be $483,970,376, with the lowest TLPH revenue forecast at $483,970,376, and the highest TLPH revenue forecast at $483,970,376.
In 2028, TLPH is forecast to generate $1,016,474,022 in revenue, with the lowest revenue forecast at $1,016,474,022 and the highest revenue forecast at $1,016,474,022.